Biotech Regulatory Affairs Consulting
Innovative therapies such as cell and gene treatments, CAR-T, monoclonal antibodies and peptides are reshaping the future of medicine. Yet, their path to market in China and across Asia Pacific is defined by intricate, rapidly evolving regulatory frameworks. At Cisema, we specialize in guiding biotech companies through these complexities with precision and confidence. Our regulatory affairs consulting is purpose-built for novel therapies.
From early-stage clinical trial applications to post-market lifecycle management, our team delivers strategic support grounded in decades of experience and deep regional insight. We help you align with regulatory expectations, avoid costly delays, and accelerate market access across APAC, including China.
Success in Asia Pacific demands country-specific adaptation, localized regulatory intelligence, proactive engagement with regulatory agencies and tailored submission strategies. Our team works as an extension of your team, streamlining approvals, mitigating risks, and ensuring compliance every step of the way.
Our Biotech Regulatory Affairs Services in China & Asia Pacific
Strategic Regulatory Expertise
We support biotechnology innovators and investors by navigating the complexities of regulatory affairs with precision and foresight. Whether you're preparing for market authorization, engaging with global health authorities, or managing compliance across regions, our team develops tailored strategies that align with your product goals and regulatory milestones.
Due Diligence & Partnering
Whether you're acquiring, licensing, or entering strategic partnerships, we provide targeted regulatory insight to support your decision-making. Our senior team helps assess risks, identify gaps, and propose mitigation strategies, ensuring confidence before you commit.
Regulatory Strategy & Agency Engagement
We help you develop a regulatory roadmap that supports your product’s lifecycle and maximizes agency alignment. Our services include:
Marketing Authorization
Our joined-up approach ensures your submission is efficient, compliant, and positioned for success across diverse regulatory landscapes.
Our joined-up approach ensures your submission is efficient, compliant, and positioned for success across diverse regulatory landscapes.
Pharmacovigilance
Pharmacovigilance (PV) is more than compliance; it’s a commitment to patient safety and product integrity. We offer flexible PV solutions from tactical support to strategic partnerships. For more details, visit our dedicated PV page.
Quality Management & Compliance
We help you build and maintain a robust Quality Management System (QMS) aligned with GxP standards. Our services include gap analysis, SOP development, inspection readiness, and remediation planning, tailored to your development stage and business model. Visit our dedicated Quality page.
Why Work with Cisema?
Deep Scientific & Regulatory Expertise in Advanced Biotech Products
We understand the complexity of next-generation therapies. Our consultants bring experience with cell-based, gene-edited, and peptide-based products, offering practical insight to support compliant and efficient development.
Local Regulatory Know-how
With teams based across Asia Pacific, we guide you through the nuances of country-specific regulations, including clinical requirements, quality documentation, and procedures for marketing authorizations for novel therapies.
Integrated Lifecycle Support
From applications for clinical trials to marketing approval and beyond, we provide continuous support to keep your product aligned with evolving regulatory requirements and expectations across the Asia Pacific region.
Proactive Risk Management & Regulatory Foresight
Our regulatory affairs professionals minimize delays and optimize outcomes with strategic planning, proactive engagement with health authorities, and a strong focus on regulatory compliance.
Frequently Asked Questions
As early as possible. Early planning is critical to align with country-specific regulatory frameworks. Strategic planning from the outset ensures smoother clinical development and faster market access.
In many cases, yes. However, bridging studies or supplemental local data may be required. We help you assess data acceptability, identify gaps, and develop region-specific strategies to meet regulatory expectations.
New modalities such as CAR-T or gene therapies present unique regulatory challenges ranging from complex manufacturing and product traceability to long-term safety monitoring. We stay on top of evolving regulations to ensure your submissions are robust and compliant.
Yes. Most jurisdictions mandate a local legal representative for regulatory filings and authority communications. Cisema provides agent services across the region, ensuring full compliance and seamless engagement with regulators.
Request a Proposal from Our Biotech Team
Let Cisema help turn your plans into reality.
Explore Related Services
Clinical Development Services
Drive successful market entry and growth with confidence. Our product development experts support biotech and pharmaceutical companies in streamlining drug development, accelerating approvals, and achieving commercialization through tailored strategies, clinical insights, and end-to-end compliance solutions.
Health Economics & Market Access
Accelerate access across China and Asia Pacific with confidence. Our market access consulting experts help life sciences companies optimize patient access, navigate pricing and reimbursement challenges, and enable commercial success through real world evidence, health economics, and tailored access strategies.
Pharmacovigilance
Ensure drug safety and regulatory compliance across China and Asia Pacific with confidence. Our pharmacovigilance consulting experts support life sciences companies in managing risks, meeting evolving safety requirements, and maintaining market authorization through end-to-end PV solutions tailored to local regulations.
Quality Management & Compliance
Ensure regulatory excellence across China and Asia Pacific with confidence. Our quality management and compliance experts help life sciences companies strengthen GxP systems, streamline audits, and maintain inspection readiness to safeguard market access and operational performance.
